Catalyst Wire Dossier Catalyst Wire Dossier

Peroneal Transcutaneous NeuroModulation

· Stimvia s.r.o.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Peroneal Transcutaneous NeuroModulation, covering 2024-08-21 to 2024-08-26. Get the full timeline:

Most recent: Clinical Trial Update: 24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]

See pricing